TNGX: Executive Chair Barbara Weber departs Tango Therapeutics, separation terms pending signature
The catalyst in focus for TNGX: Tango Therapeutics, Inc. confirmed in an August 6 SEC filing that Dr. Barbara Weber's employment as Executive Chair ended August 3, 2026, simultaneously triggering her resignation from…